Defibrillators Market, by Product Type (Implantable Cardioverter Defibrillators (Single Chamber Implantable Cardioverter Defibrillators and Dual Cardioverter Defibrillators) and External Defibrillators (Manual External Defibrillators, Automated External Defibrillators, and Wearable Cardioverter Defibrillators)), by End User (Hospitals, Cardiac Clinics, and Ambulatory Surgical Centers), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Defibrillators are used to restore normal heartbeat by sending controlled electric pulse to the heart. These devices are used to correct an arrhythmia. There are different types of defibrillators, such as implantable and external defibrillators. Defibrillators work on the principle of electrical shock transfer to the chest area of the patient. This induces impulses to the heart membrane, which stabilizes cardiac rhythm. Defibrillator is also considered as an effective resuscitation tool in emergency medical services.
Market Dynamics
High incidence of cardiac disorders along with increasing technological advancements, product launches, and healthcare expenditure are major factors driving the global defibrillators market growth. For instance in 2019, according to the Center for Medicare and Medicaid Services’ report, the national healthcare expenditure is projected to increase by 4.8% in 2019, up from 4.4% in 2021, to reach US$ 3.8 trillion in the U.S.
Furthermore, key players in the market are focused on adopting growth strategies such as mergers and acquisitions and product development to expand their product portfolio, which is expected to drive the market growth. For instance, in June 2019, Koninklijke Philips N.V. received U.S. Food and Drug Administration (FDA) premarket approvals for automated external defibrillators, HeartStart OnSite defibrillator and HeartStart Home defibrillator.
Key features of the study:
This report provides in-depth analysis of the defibrillators market and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2022 - 2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategy adopted by key players
It profiles key players in the global defibrillators market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Koninklijke Philips N.V., Metrax GmbH, Mindray Medical International Limited, Boston Scientific Corporation, GE Healthcare, Nihon Kohden, Abbott, BIOTRONIK, and LivaNova PLC
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
The global defibrillators market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global defibrillators market
Detailed Segmentation:
Global Defibrillators Market, By Product Type:
Implantable Cardioverter Defibrillators
Single Chamber Implantable Cardioverter Defibrillators
Dual Chamber Implantable Cardioverter Defibrillators
External Defibrillators
Manual External Defibrillators
Automated External Defibrillators
Wearable Cardioverter Defibrillators
Global Defibrillators Market, By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
Global Defibrillators Market, By Region:
North America
By Product Type:
Implantable Cardioverter Defibrillators
Single Chamber Implantable Cardioverter Defibrillators
Dual Chamber Implantable Cardioverter Defibrillators
External Defibrillators
Manual External Defibrillators
Automated External Defibrillators
Wearable Cardioverter Defibrillators
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
U.S.
Canada
Latin America
By Product Type:
Implantable Cardioverter Defibrillators
Single Chamber Implantable Cardioverter Defibrillators
Dual Chamber Implantable Cardioverter Defibrillators
External Defibrillators
Manual External Defibrillators
Automated External Defibrillators
Wearable Cardioverter Defibrillators
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
Brazil
Mexico
Argentina
Rest of Latin America
Europe
By Product Type:
Implantable Cardioverter Defibrillators
Single Chamber Implantable Cardioverter Defibrillators
Dual Chamber Implantable Cardioverter Defibrillators
External Defibrillators
Manual External Defibrillators
Automated External Defibrillators
Wearable Cardioverter Defibrillators
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
Germany
U.K.
France
Italy
Spain
Russia
Rest of Europe
Asia Pacific
By Product Type:
Implantable Cardioverter Defibrillators
Single Chamber Implantable Cardioverter Defibrillators
Dual Chamber Implantable Cardioverter Defibrillators
External Defibrillators
Manual External Defibrillators
Automated External Defibrillators
Wearable Cardioverter Defibrillators
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
Middle East
By Product Type:
Implantable Cardioverter Defibrillators
Single Chamber Implantable Cardioverter Defibrillators
Dual Chamber Implantable Cardioverter Defibrillators
External Defibrillators
Manual External Defibrillators
Automated External Defibrillators
Wearable Cardioverter Defibrillators
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country:
GCC
Israel
Rest of Middle East
Africa
By Product Type:
Implantable Cardioverter Defibrillators
Single Chamber Implantable Cardioverter Defibrillators
Dual Chamber Implantable Cardioverter Defibrillators
External Defibrillators
Manual External Defibrillators
Automated External Defibrillators
Wearable Cardioverter Defibrillators
By End User:
Hospitals
Cardiac Clinics
Ambulatory Surgical Centers
By Country/Region:
South Africa
Central Africa
North Africa
Company Profiles
Koninklijke Philips N.V.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Metrax GmbH
Medtronic
Mindray Medical International Limited
Boston Scientific Corporation
GE Healthcare
Nihon Kohden
Abbott
BIOTRONIK
Stryker
LivaNova PLC
“*” marked represents similar segmentation in other categories in the respective section.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook